Immunome IMNM Q2 2025 earnings
Reported August 6, 2025 · Before market open
Revenue estimate$833.3K
EPS estimate-$0.52
Next report
Aug 5, 2026 (In 3 weeks)Revenue estimate$166.7K
EPS estimate-$0.51
Financials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Immunome reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Immunome report Q2 2025 earnings?
- Immunome (IMNM) reported Q2 2025 earnings on August 6, 2025 before market open.
- What were Immunome's Q2 2025 revenue and EPS?
- Immunome reported revenue of $4.0M and diluted EPS of $-0.50 for Q2 2025.
- Did Immunome beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $833.3K by $3.2M. EPS beat the consensus estimate of $-0.52 by $0.02.
- How did Immunome's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 69.8% from $2.4M a year earlier and diluted EPS declined 2.0% from $-0.49.
- Where can I find Immunome's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-104035) directly on SEC EDGAR. The filing index links above go to sec.gov.